Skip to main content

Danske Bank A/S

Source: SEC Form 13F · as of Mar 2026

Danske Bank A/S holds 48 biotech & pharma companies tracked by BioSniper, totaling $262.9M in value as of Mar 2026 (SEC Form 13F).

Companies held

48

Total value held

$262.9M

BioSniper AIPage context preserved

Prepared research question

What matters most for GILEAD SCIENCES, INC. (GILD)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
GILDGILEAD SCIENCES, INC.857,393$119.5M
REGNREGENERON PHARMACEUTICALS, INC.107,220$82.8M
ALNYALNYLAM PHARMACEUTICALS, INC.65,955$21.8M
INSMINSMED Inc111,058$18.2M
TEVATeva Pharmaceutical Industries Limited284,939$8.6M
INCYIncyte Corp.77,085$7.3M
RVMDREVOLUTION MEDICINES, INC.44,900$4.4M
BMRNBIOMARIN PHARMACEUTICAL INC3,000$169K
MRNAModerna, Inc.2,351$119K
BBIOBridgeBio Pharma, Inc.200$15K
CYTKCYTOKINETICS INC200$13K
PCVXVaxcyte, Inc.200$12K
RYTMRHYTHM PHARMACEUTICALS, INC.100$9K
ROIVRoivant Sciences Ltd.300$8K
IONSIONIS PHARMACEUTICALS INC100$8K
INVAInnoviva, Inc.300$7K
ARWRARROWHEAD PHARMACEUTICALS, INC.100$6K
EXELEXELIXIS, INC.100$4K
NTLAIntellia Therapeutics, Inc.200$3K
OGNOrganon & Co.200$1K
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)11$607
RNAAtrium Therapeutics Inc.21$280
NKTRNEKTAR THERAPEUTICS2$144
PPBTPURPLE BIOTECH LTD.4$16
IXHLIncannex Healthcare Inc.5$15
CODXCo-Diagnostics Inc.7$13
RLYBRallybio Corp1$9
KYNBKYNTRA BIO INC.1$7
ACETAdicet Bio, Inc.1$7
RVPHREVIVA PHARMACEUTICALS HOLDINGS, INC.7$5
CLRBCellectar Biosciences, Inc.2$5
EDSAEdesa Biotech, Inc.1$5
GRIGRI Bio, Inc.2$5
ATHEAlterity Therapeutics Limited1$4
CRVOCervoMed Inc.1$4
HLSQBiomX Inc.1$4
GOVXGeoVax Labs, Inc.3$4
ADTXAditxt, Inc.3$3
HURATuHURA Biosciences, Inc./NV1$2
VERUVERU INC.1$2
MTVAMetaVia Inc.2$2
ENVBEnveric Biosciences, Inc.1$2
CELUCelularity Inc.1$1
AEONAEON Biopharma, Inc.1$1
BIVIBIOVIE INC.1$1
MBIOMUSTANG BIO, INC.2$1
CPHICHINA PHARMA HOLDINGS, INC.1$1
TOVXTheriva Biologics, Inc.1$0

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.